Page 4 - Brian Goff News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Headlands Technologies LLC raised its holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) by 31.3% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 9,037 shares of the biopharmaceutical company’s stock after acquiring an additional 2,153 shares during the quarter. Headlands Technologies LLC’s holdings […]

1. The pessimistic view on Ethiopia. 2. Inside the NBA’s chess club. 3. Brian Goff on education and the cost disease. 4. Genes and depression and bad luck is…

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) – Analysts at Zacks Research raised their FY2024 EPS estimates for Agios Pharmaceuticals in a note issued to investors on Thursday, January 25th. Zacks Research analyst A. Chakraborty now anticipates that the biopharmaceutical company will post earnings of ($6.05) per share for the year, up from their previous […]

Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Get Free Report) were up 5.2% on Thursday . The company traded as high as $23.24 and last traded at $22.62. Approximately 365,022 shares changed hands during mid-day trading, a decline of 62% from the average daily volume of 962,941 shares. The stock had previously closed at $21.51. […]

Brian Goff, CEO of Agios Pharmaceuticals Inc (NASDAQ:AGIO), executed a sale of 12,066 shares in the company on January 9, 2024, according to a recent SEC filing.